Association between expression levels of CA 19-9 and N-acetylglucosamine-β1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue

Pathobiology

Volumn 71, Issue 1, 2004, Pages 26-34

  Hayashi, Nobuyasu ^a   Nakamori, Shoji ^a,c   Okami, Jiro ^a   Nagano, Hiroaki ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Sakon, Masato ^a   Narimatsu, Hisashi ^b   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b SOKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

3Gal T5; CA 19 9; DUPAN 2; Gene expression; Immunoreactivity; Quantification

Indexed keywords

CA 19-9 ANTIGEN; DUPAN 2; GLYCOSYLTRANSFERASE; N ACETYLGLUCOSAMINE BETA 1,3 GALACTOSYLTRANSFERASE 5; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ANALYSIS; ENZYME KINETICS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; ANTIGENS, NEOPLASM; CA-19-9 ANTIGEN; FEMALE; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0141924160     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072959     Document Type: Article

References (42)

1. Nicolson GL: Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta 1982;695: 113-176.
2. Hakomori S: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
3. Feizi T: Monoclonal antibodies point to carbohydrate structures as tumour-associated antigens. Med Biol 1983;61:144-146.
4. Dennis JW, Laferte S: Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells. Cancer Res 1985: 6034-6040.
5. Kleene R, Berger EG: The molecular and cell biology of glycosyltransferases. Biochim Biophys Acta 1993;1154:283-325.
6. Magnani JL, Nilsson B, Brockhaus M, et al: A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 1982;257:14365-14369.
7. Nakao A, Oshima K, Nomoto S, et al: Clinical usefulness of CA-19-9 in pancreatic carcinoma. Semin Surg Oncol 1998;15:15-22.
8. Safi F, Schlosser W, Falkenreck S, Beger HG: CA 19-9 serum course and prognosis of pancreatic cancer. Int J Pancreatol 1996;20:155-161.
9. Montgomery RC, Hoffman JP, Riley LB, Rogatko A, Ridge JA, Eisenberg BL: Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 1997;4:551-556.
10. Marrelli D, Roviello F, De Stefano A, et al: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999;57:55-62.
11. Nakayama T, Watanabe M, Teramoto T, Kitajima M: CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238-243.
12. Shimono R, Mori M, Akazawa K, Adachi Y, Sgimachi K: Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma. Am J Gastroenterol 1994;89:101-105.
13. Nakamori S, Furukawa H, Hiratsuka M, et al: Expression of carbohydrate antigen sialyl Le(a): A new functional prognostic factor in gastric cancer. J Clin Oncol 1997;15:816-825.
14. Yazawa S, Nakamura J, Asao T, et al: Aberrant α 1→ 2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors. Jpn J Cancer Res 1993;84:989-995.
15. Kudo T, Ikehara Y, Togayachi A, et al: Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 1998;78: 797-811.
16. Nakamori S, Nishihara S, Ikehara Y, et al: Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas. J Exp Clin Cancer Res 1999;18:425-432.
17. Hennet T, Dinter A, Kuhnert P, Mattu TS, Rudd PM, Berger EG: Genomic cloning and expression of three murine UDP-galactose: β -N-acetylglucosamine β1,3-galactosyltransferase genes. J Biol Chem 1998;273:58-65.
18. Kolbinger F, Streiff MB, Katopodis AG: Cloning of a human UDP-galactose:2-Acetamido-2-deoxy-D-glucose 3β-galactosyltransferase catalyzing the formation of type 1 chains. J Biol Chem 1998;273:433-440.
19. Amado M, Almeida R, Carneiro F, et al: A family of human β3-galactosyltransferases. Characterization of four members of a UDP-galactose: β-N-acetyl-glucosamine/β-nacetyl-galactosamine β-1,3-galactosyltransferase family. J Biol Chem 1998;273:12770-12778.
20. Isshiki S, Togayachi A, Kudo T, et al: Cloning, expression, and characterization of a novel UDP-galactose: β-N-acetylglucosamine β1,3-galactosyltransferase (β3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom. J Biol Chem 1999;274:12499-12507.
21. Zhou D, Dinter A, Gutierrez GR, et al: Aβ -1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to β-1,3-galactosyltransferases. Proc Natl Acad Sci USA 1999;96:406-411.
22. Sobin LH, Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80:1803-1804.
23. Yazawa S, Nishihara S, Iwasaki H, et al: Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 1995;55:1473-1478.
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
25. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ: The LightCycler: A microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997;22:176-181.
26. Miyamoto A, Nagano H, Sakon M, et al: Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR. Int J Oncol 2000;18:527-532.
27. Chretien S, Dubart A, Beaupain D, et al: Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci USA 1988;85:6-10.
28. Law KL, Smith DF: III6NeuAcLc4Cer in human SW1116 colorectal carcinoma cells: A possible oncofetal antigen that is not dependent on Lewis gene expression. Arch Biochem Biophys 1987;258:315-323.
29. Pals G, Pindolia K, Worsham MJ: A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example. Mol Diagn 1999;4:241-246.
30. Woo TH, Patel BK, Smythe LD, et al: Identification of Leptospira inadai by continuous monitoring of fluorescence during rapid cycle PCR. Syst Appl Microbiol 1998;21:89-96.
31. Hayashi N, Yamamoto H, Hiraoka N, et al: Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology 2001;34:638-650.
32. Kawa S, Oguchi H, Kobayashi T, et al: Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype. Br J Cancer 1991;64:899-902.
33. Boring CC, Squires TS, Tong T, Montgomery S: Cancer statistics, 1994. Ca Cancer J Clin 1994;44:7-26.
34. Wanebo HJ, Vezeridis MP: Pancreatic carcinoma in perspective. A continuing challenge. Cancer 1996:580-591.
35. Orntoft TF, Meldgaard P, Pedersen B, Wolf H: The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res 1996;56:1031-1036.
36. Togayachi A, Kudo T, Ikehara Y, et al: Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type α1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer. Int J Cancer 1999;83:70-79.
37. Tsuji S: Molecular cloning and functional analysis of sialyltransferases. J Biochem (Tokyo) 1996;120:1-13.
38. Pierce M, Buckhaults P, Chen L, Fregien N: Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide β(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 1997;14:623-630.
39. Lo NW, Shaper JH, Pevsner J, Shaper NL: The expanding β4-galactosyltransferase gene family: Messages from the databanks. Glycobiology 1998;8:517-526.
40. Pellegata NS, Sessa F, Renault B, et al: K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54: 1556-1560.
41. Narimatsu H, Iwasaki H, Nakayama F, et al: Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res 1998;58:512-518.
42. Toshkov I, Mogaki M, Kazakoff K, Pour PM: The patterns of coexpression of tumor-associated antigens CA 19-9, TAG-72, and DU-PAN-2 in human pancreatic cancer. Int J Pancreatol 1994;15:97-103.